The risk of micro and macrovascular disease in Egyptian patients with diabetes and peripheral arterial disease

Figures & data

Table 1. Demographic data of the studied group

		abnormal ABI
		n	%
Sex	male	53	32.9%
	Female	108	67.1%
Type of DM	Type 1	14	8.7%
	Type 2	147	91.3%
HTN		84	52.2%
IHD		37	23.0%
Smoking		41	25.5%
High Urine ACR		82	50.9%
Diabetic Retinopathy		110	68.3%
Foot deformity		52	32.3%
Lost DP Pulses		20	12.4%
Foot Ulcers		12	7.5%
Lost Superficial Sensations		61	37.9%
Lost Vibration Sense		71	44.1%

n, number of patients; DM, diabetes mellitus; HTN, hypertension; IHD, ischemic heart disease; ACR, albumin/creatinine ratio; DP, dorsalis pedis; ABI, ankle/brachial index.

Table 2. Multivariate regression analysis for patients with ABI< 0.9

		P value	OR	95% CI
				Lower	Upper
	Neuropathy	<0.001*	15.904	3.760	67.271
	Nephropathy	<0.05*	4.169	1.043	16.675
	Creatinine	<0.001*	11.502	4.271	30.977
	TG	<0.001*	1.016	1.008	1.023
	LDL	<0.01*	0.984	0.974	0.995
	Low HDL	<0.001*	0.919	0.880	0.960

ABI, ankle/brachial index; OR, odds ratio; CI, confidence interval; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein; *, significant.

Table 3. Multivariate regression analysis for patients with ABI> 1.3

		P value	OR	95% CI
				Lower	Upper
ABI>1.3	IHD	<0.001*	7.333	3.428	15.685
	Lost Superficial Sensations	<0.001*	2.569	1.442	4.577
	Lost Deep Sensations	<0.05*	2.014	1.158	3.502
	DBP	<0.05*	0.972	0.950	0.995
	TG	<0.01*	1.006	1.002	1.010

ABI, ankle/brachial index; OR, odds ratio; CI, confidence interval; IHD, ischemic heart disease; DBP, diastolic blood pressure; TG, triglycerides; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein; *, significant.